3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine

C139H157F13N52O10S — CID 158559266

IUPAC3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine
SMILESCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1.CN.CN.COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F.Cc1nc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c2cc(F)ccc2n1.Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1.Nc1ncc(-c2nc(N3CCOCC3)ncc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1.Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1
InChIInChI=1S/C25H26FN9O.C24H26F3N9O2.C23H25F3N8O2.C22H23F3N8O2.C22H27N9O2S.C21H20F3N7O.2CH5N/c1-14-31-17-6-5-15(26)12-16(17)20(32-14)18-13-30-22(27)21(33-18)24(36)34-23-19(4-3-9-29-23)35-10-7-25(2,28)8-11-35;25-24(26,27)15-13-31-23(36-9-11-38-12-10-36)33-18(15)16-14-30-20(28)19(32-16)22(37)34-21-17(5-4-6-29-21)35-7-2-1-3-8-35;1-22(28)6-10-34(11-7-22)14-4-3-8-30-20(14)33-21(35)18-19(27)31-12-13(32-18)17-16(23(24,25)26)15(36-2)5-9-29-17;1-21(27)6-10-33(11-7-21)14-4-2-9-29-19(14)32-20(34)17-18(26)30-12-13(31-17)16-15(5-3-8-28-16)35-22(23,24)25;23-14-3-6-30(7-4-14)17-2-1-5-25-20(17)29-21(32)18-19(24)26-12-15(27-18)16-13-34-22(28-16)31-8-10-33-11-9-31;22-21(23,24)13-6-4-8-26-16(13)14-12-28-18(25)17(29-14)20(32)30-19-15(7-5-9-27-19)31-10-2-1-3-11-31;2*1-2/h3-6,9,12-13H,7-8,10-11,28H2,1-2H3,(H2,27,30)(H,29,34,36);4-6,13-14H,1-3,7-12H2,(H2,28,30)(H,29,34,37);3-5,8-9,12H,6-7,10-11,28H2,1-2H3,(H2,27,31)(H,30,33,35);2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34);1-2,5,12-14H,3-4,6-11,23H2,(H2,24,26)(H,25,29,32);4-9,12H,1-3,10-11H2,(H2,25,28)(H,27,30,32);2*2H2,1H3
InChIKeyHQRHOBAIEQRBIC-UHFFFAOYSA-N
MW2995.18 g/mol
LogP16.71
Rot. Bonds28

About 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine

3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine (PubChem CID 158559266) has the molecular formula C139H157F13N52O10S and a molecular weight of 2995.18 g/mol. Its IUPAC name is 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine.

Molecular Properties

Compound Name3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine
PubChem CID158559266
Molecular FormulaC139H157F13N52O10S
Molecular Weight2995.18 g/mol
Exact Mass2993.29
IUPAC Name3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine
SMILESCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1.CN.CN.COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F.Cc1nc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c2cc(F)ccc2n1.Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1.Nc1ncc(-c2nc(N3CCOCC3)ncc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1.Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1
InChIInChI=1S/C25H26FN9O.C24H26F3N9O2.C23H25F3N8O2.C22H23F3N8O2.C22H27N9O2S.C21H20F3N7O.2CH5N/c1-14-31-17-6-5-15(26)12-16(17)20(32-14)18-13-30-22(27)21(33-18)24(36)34-23-19(4-3-9-29-23)35-10-7-25(2,28)8-11-35;25-24(26,27)15-13-31-23(36-9-11-38-12-10-36)33-18(15)16-14-30-20(28)19(32-16)22(37)34-21-17(5-4-6-29-21)35-7-2-1-3-8-35;1-22(28)6-10-34(11-7-22)14-4-3-8-30-20(14)33-21(35)18-19(27)31-12-13(32-18)17-16(23(24,25)26)15(36-2)5-9-29-17;1-21(27)6-10-33(11-7-21)14-4-2-9-29-19(14)32-20(34)17-18(26)30-12-13(31-17)16-15(5-3-8-28-16)35-22(23,24)25;23-14-3-6-30(7-4-14)17-2-1-5-25-20(17)29-21(32)18-19(24)26-12-15(27-18)16-13-34-22(28-16)31-8-10-33-11-9-31;22-21(23,24)13-6-4-8-26-16(13)14-12-28-18(25)17(29-14)20(32)30-19-15(7-5-9-27-19)31-10-2-1-3-11-31;2*1-2/h3-6,9,12-13H,7-8,10-11,28H2,1-2H3,(H2,27,30)(H,29,34,36);4-6,13-14H,1-3,7-12H2,(H2,28,30)(H,29,34,37);3-5,8-9,12H,6-7,10-11,28H2,1-2H3,(H2,27,31)(H,30,33,35);2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34);1-2,5,12-14H,3-4,6-11,23H2,(H2,24,26)(H,25,29,32);4-9,12H,1-3,10-11H2,(H2,25,28)(H,27,30,32);2*2H2,1H3
InChIKeyHQRHOBAIEQRBIC-UHFFFAOYSA-N
XLogP16.71
TPSA884.82 Ų
H-Bond Donors18
H-Bond Acceptors57
Rotatable Bonds28
Heavy Atoms215
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002995.18
LogP ≤ 516.71
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1057

Analyze 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine?
The IUPAC name of 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine (CID 158559266) is 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine.
What is the SMILES notation for 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine?
The canonical SMILES for 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine is CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1.CN.CN.COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F.Cc1nc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c2cc(F)ccc2n1.Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1.Nc1ncc(-c2nc(N3CCOCC3)ncc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1.Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCCCC1.
What is the InChIKey of 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine?
The InChIKey is HQRHOBAIEQRBIC-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26FN9O.C24H26F3N9O2.C23H25F3N8O2.C22H23F3N8O2.C22H27N9O2S.C21H20F3N7O.2CH5N/c1-14-31-17-6-5-15(26)12-16(17)20(32-14)18-13-30-22(27)21(33-18)24(36)34-23-19(4-3-9-29-23)35-10-7-25(2,28)8-11-35;25-24(26,27)15-13-31-23(36-9-11-38-12-10-36)33-18(15)16-14-30-20(28)19(32-16)22(37)34-21-17(5-4-6-29-21)35-7-2-1-3-8-35;1-22(28)6-10-34(11-7-22)14-4-3-8-30-20(14)33-21(35)18-19(27)31-12-13(32-18)17-16(23(24,25)26)15(36-2)5-9-29-17;1-21(27)6-10-33(11-7-21)14-4-2-9-29-19(14)32-20(34)17-18(26)30-12-13(31-17)16-15(5-3-8-28-16)35-22(23,24)25;23-14-3-6-30(7-4-14)17-2-1-5-25-20(17)29-21(32)18-19(24)26-12-15(27-18)16-13-34-22(28-16)31-8-10-33-11-9-31;22-21(23,24)13-6-4-8-26-16(13)14-12-28-18(25)17(29-14)20(32)30-19-15(7-5-9-27-19)31-10-2-1-3-11-31;2*1-2/h3-6,9,12-13H,7-8,10-11,28H2,1-2H3,(H2,27,30)(H,29,34,36);4-6,13-14H,1-3,7-12H2,(H2,28,30)(H,29,34,37);3-5,8-9,12H,6-7,10-11,28H2,1-2H3,(H2,27,31)(H,30,33,35);2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34);1-2,5,12-14H,3-4,6-11,23H2,(H2,24,26)(H,25,29,32);4-9,12H,1-3,10-11H2,(H2,25,28)(H,27,30,32);2*2H2,1H3.
What are the key properties of 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine?
3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine has a molecular weight of 2995.18 g/mol, XLogP of 16.71, 28 rotatable bonds, 18 hydrogen bond donors, and 57 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-(6-fluoro-2-methylquinazolin-4-yl)pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[4-methoxy-3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethoxy)-2-pyridinyl]pyrazine-2-carboxamide;3-amino-N-[3-(4-aminopiperidin-1-yl)-2-pyridinyl]-6-(2-morpholin-4-yl-1,3-thiazol-4-yl)pyrazine-2-carboxamide;3-amino-6-[2-morpholin-4-yl-5-(trifluoromethyl)pyrimidin-4-yl]-N-(3-piperidin-1-yl-2-pyridinyl)pyrazine-2-carboxamide;3-amino-N-(3-piperidin-1-yl-2-pyridinyl)-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide;methanamine is sourced from PubChem (CID 158559266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).